Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.
Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.
复制标题
DOI:
10.1186/1475-2840-13-12
复制
发表时间:
2014-01-11
影响因子:
9.3
通讯作者:
Dutka DP
中科院分区:
文献类型:
--
作者:
Clarke SJ;McCormick LM;Dutka DP
Coronary heart disease and type-2 diabetes are both major global health burdens associated with an increased risk of myocardial infarction (MI). Following MI, ischaemia-reperfusion injury (IRI) remains a significant contributor to myocardial injury at the cellular level. Research has focussed on identifying a strategy or intervention to minimise IRI to optimise reperfusion therapy, with the aim of delivering a superior clinical outcome. The incretin hormone glucagon-like peptide-1, already an established basis for the treatment of type-2 diabetes, also has the potential to protect against IRI. We explain the physiology and cellular processes involved in IRI, and the intracellular pathways activated by GLP-1, which could intercept IRI and deliver cardioprotection. The review also examines the current preclinical and clinical evidence for GLP-1 in cardioprotection and future directions for research as we look for an effective adjunctive treatment to minimise IRI.
登录
查看更多内容
影响因子:
3
作者:
BERNARDI, P;BROEKEMEIER, KM;PFEIFFER, DR
通讯作者:
PFEIFFER, DR
影响因子:
3.9
作者:
Halestrap, Andrew P.
通讯作者:
Halestrap, Andrew P.
影响因子:
3.9
作者:
Green, Brian D.;Hand, Katharine V.;Grieve, David J.
通讯作者:
Grieve, David J.
影响因子:
20.1
作者:
Clarke, Samantha J.;Khaliulin, Igor;Das, Manika;Parker, Joanne E.;Heesom, Kate J.;Halestrap, Andrew P.
通讯作者:
Halestrap, Andrew P.
影响因子:
5
作者:
Argaud, Laurent;Gateau-Roesch, Odile;Ovize, Michel
通讯作者:
Ovize, Michel